CPNE1 and breast carcinoma: Our findings indicated a negative association between CPNE1 and breast cancer risk (OR: 0.94, 95% CI: 0.90-0.98), and Ren’s study yielded similar results (OR: 0.96, 95% CI: 0.94-0.98).